REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17/03/2025
Voltar para busca
Dado oficial do USPTO
DIGITOME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
17/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
15/09/2018
Data de registro
17/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/03/2020
Última transação
17/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
11/10/2017
Primeiro uso no comércio
11/10/2017
Código do desenho
4
Tipo de titular
03
Localização do titular
Palo Alto, CA
Examinador
MURRAY, TY
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Medable, Inc.
Representantes
Omar M. Wadhwa Cesari and McKenna, LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Software as a service (SAAS) serviceshosting software for use by others for use for disease progression prediction; Software as a service (SAAS) serviceshosting software for use by others for use for medical status assessment; Software as a service (SAAS) serviceshosting software for use by others for use for overall health assessment; Software as a service (SAAS) serviceshosting software for use by others for use to determine effective therapies and medications; Software as a service (SAAS) serviceshosting software for use by others for use to make medical decisions; Application service provider (ASP) featuring software for use in the collectionprocessingstorage and exchange of human health and disease data; Application service provider (ASP) featuring software for use in the collectionprocessingstorage and exchange of genetic data; Application service provider (ASP) featuring software for use to derive insights and or understanding about human health and disease.; Application service provider (ASP) featuring software for use for predictive analytics; Application service provider (ASP) featuring software for use for disease progression prediction; Application service provider (ASP) featuring software for use for medical status assessment; Application service provider (ASP) featuring software for use for overall health assessment; Application service provider (ASP) featuring software for use to determine effective therapies and medications; Application service provider (ASP) featuring software for use to make medical decisions; Application service provider (ASP) featuring software for use to assist in overall medical and therapeutic decision making; Conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Medical and scientific researchconducting clinical trials for others; Platform as a service (PAAS) featuring computer software platforms for in the collectionprocessingstorage and exchange of human health and disease data; Platform as a service (PAAS) featuring computer software platforms for in the collectionprocessingstorage and exchange of genetic data; Platform as a service (PAAS) featuring computer software platforms for to derive insights and or understanding about human health and disease.; Platform as a service (PAAS) featuring computer software platforms for for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for for medical status assessment; Platform as a service (PAAS) featuring computer software platforms for for overall health assessment; Platform as a service (PAAS) featuring computer software platforms for to determine effective therapies and medications; Platform as a service (PAAS) featuring computer software platforms for to make medical decisions; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Classe 44
Health care servicesproviding a database in the field of disease detection and management information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care servicesproviding a database in the field of disease therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/12/2019
PUBO
PUBLISHED FOR OPPOSITION
31/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
26/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
26/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2019
GNRT
NON-FINAL ACTION E-MAILED
06/10/2019
CNRT
NON-FINAL ACTION WRITTEN
06/10/2019
NREV
NOTICE OF REVIVAL - E-MAILED
30/09/2019
PETG
PETITION TO REVIVE-GRANTED
30/09/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
30/09/2019
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
30/07/2019
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
30/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/01/2019
GNRT
NON-FINAL ACTION E-MAILED
01/01/2019
CNRT
NON-FINAL ACTION WRITTEN
01/01/2019
DOCK
ASSIGNED TO EXAMINER
27/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/09/2018
NWAP
NEW APPLICATION ENTERED
19/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIGITOME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.